Eiger BioPharmaceuticals Hits Ch. 11 With $53.1M Debt
By Alex Wittenberg · April 1, 2024, 12:05 PM EDT
Eiger BioPharmaceuticals Inc. filed for Chapter 11 protection in Texas bankruptcy court Monday with $53.1 million of debt and plans to sell its assets during the case....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login